Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times
The global coronavirus pandemic has tested the abilities of bio/pharmaceutical companies to develop new therapies and maintain-or even accelerate-production of existing drugs. In this webcast, experts will discuss business continuity practices, regulatory compliance, and supply chain management under current-or future-emergency conditions. Live: Tuesday, Apr. 28, 2020 at 11 am EDT | 10 am CDT | 8 am PDT On Demand: available after airing until Apr. 28, 2021 Register free
Register free: http://www.pharmtech.com/pt_w/business_continuity_practices
Event Overview:
The global coronavirus pandemic has tested the abilities of bio/pharmaceutical companies to develop new therapies and maintain-or even accelerate-production of existing drugs. Travel bans, restricted access to facilities, and supply chain disruptions are just a few of the challenges facing drug companies, that must provide essential medicines under adverse conditions while protecting their employees and adhering to good manufacturing practices.
In the initial weeks of the coronavirus pandemic, bio/pharma companies, contract service providers, and regulatory authorities have taken measures to ensure continued operations during the present emergency. While addressing the challenges of today, the bio/pharma industry also needs to look ahead to what may be new operating conditions for the coming months or years.
Join the editors of Pharmaceutical Technology and BioPharm International for interviews and discussions with experts about business continuity practices, regulatory compliance, and supply chain management under current-or future-emergency conditions.
Key Learning Objectives:
- Business continuity best practices
- Employee and facility safety
- Regulatory compliance
- Addressing deviations
- Testing guidance for new and existing drugs
- Supplier oversight
- Supply chain challenges
- Data security, data integrity, and remote data access and collaboration
Speakers: Mary Blenn, vice-president, global supply chain, Cytiva
Lisia Marina Scholz Dias, lead application engineer, Applied Materials
Steve Goldman, head of Steve Goldman Associates, a risk management and business continuity consultancy
David Light, CEO of Valisure
Ron Najafi, CEO of Emery Pharma
Susan Schniepp, a distinguished fellow for Regulatory Compliance Associates
Angelo Stracquatanio, CEO, apprentice.io
Japp Venema, CSO, USP
Time and Date: Tuesday, Apr. 28, 2020 at 11 am EDT | 10 am CDT | 8 am PDT
On demand available after airing until Apr. 28, 2021.
Sponsors: Honeywell, AbbVie, Applied Materials
Register free: http://www.pharmtech.com/pt_w/business_continuity_practices
